Fenofibrate Tablet
Product Images NDC 0904-7161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 0904-7161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5793281e 4b4f 44a1 9edd Fc4b2d4630e3 01)

Image (5793281e 4b4f 44a1 9edd Fc4b2d4630e3 01)
Chemical structure of fenofibrate showing the arrangement of its aromatic rings, chlorinated phenyl group, carbonyl groups, and ester linkages.*
FDA Label Image

Carton Label (Bbffd586 F63a 4a84 Bdfb 3e4a1df6449e 00)

Carton Label (Bbffd586 F63a 4a84 Bdfb 3e4a1df6449e 00)
FENOFIBRATE TABLETS, USP 145 mg oral tablet bottle label by Major Pharmaceuticals. This prescription medication label shows 100 tablets in a unit dose package. The label includes the NDC 0904-7161-61 and notes that each film-coated tablet contains fenofibrate 145 mg. Directions, storage conditions, and manufacturing details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.